COVID-19 Manufacturing for Monoclonal Antibodies (Updated August 2020)

covid

Policy Brief

COVID-19 Manufacturing for Monoclonal Antibodies (Updated August 2020)

Published date

June 22, 2020

Duke-Margolis Authors

Mark McClellan

Mark McClellan, MD, PhD

Director of the Duke-Margolis Institute for Health Policy
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty